Watchlist Price Alert

C4 Therapeutics Inc. (CCCC)

NASDAQ: CCCC · Real-Time Price · USD

1.47

-0.07 (-4.55%)

At close: Jun 05, 2025, 3:59 PM

1.46

-0.34%

Pre-market: Jun 06, 2025, 05:41 AM EDT

C4 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	55.5M	126.59M	29.75M	76.12M	181.73M	90.55M	36.31M
Short-Term Investments	189.41M	127.09M	246.4M	233.16M	189.96M	n/a	n/a
Long-Term Investments	22.36M	28.01M	60.96M	142.2M	2.58M	2.58M	2.58M
Other Long-Term Assets	6.1M	6.17M	4.8M	3.82M	n/a	n/a	n/a
Receivables	3.1M	11.8M	1.47M	5.72M	4.48M	4.62M	86.44M
Inventory	n/a	n/a	-60.96M	n/a	n/a	n/a	n/a
Other Current Assets	9.76M	5.71M	9.93M	10.69M	4.84M	1.59M	n/a
Total Current Assets	257.77M	271.19M	287.56M	325.69M	381.01M	96.77M	123.53M
Property-Plant & Equipment	63.38M	71.09M	77.52M	35.05M	16.55M	18.92M	20.38M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	91.83M	105.26M	143.28M	181.08M	19.13M	21.49M	22.96M
Total Assets	349.6M	376.45M	430.84M	506.76M	400.14M	118.26M	146.49M
Account Payables	1.33M	1.45M	1.17M	4.51M	5.68M	5.38M	1.15M
Deferred Revenue	18.71M	15.47M	33.51M	31.8M	27.6M	20.7M	19.11M
Short-Term Debt	5.77M	n/a	6.99M	1.33M	1.04M	880K	n/a
Other Current Liabilities	9.3M	13.29M	8.24M	7.19M	4.76M	24.33M	1.26M
Total Current Liabilities	45.18M	42.77M	44.55M	51.25M	43.85M	33.64M	23.95M
Long-Term Debt	n/a	n/a	9.2M	41.55M	21.88M	12.87M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-30.78M	-11.83M	111M	111M
Total Long-Term Liabilities	88.44M	87.57M	97.06M	65.91M	75.5M	196.58M	202.29M
Total Liabilities	133.62M	130.34M	141.61M	117.16M	119.35M	230.22M	226.24M
Total Debt	65.76M	70.98M	87.15M	42.88M	22.92M	13.75M	14.48M
Common Stock	7K	6K	5K	5K	4K	1K	1K
Retained Earnings	-633.7M	-528.38M	-395.89M	-267.71M	-183.82M	-117.49M	-83.39M
Comprehensive Income	53K	-127K	-4.14M	-775K	13K	-1K	-2.5M
Shareholders Equity	215.99M	246.11M	289.23M	389.61M	280.79M	-111.96M	-79.75M
Total Investments	211.76M	155.1M	307.36M	375.36M	189.96M	2.58M	2.58M